Philip Burchard is the CEO of Merz Therapeutics.
972 people are employed at Merz Therapeutics.
Merz Therapeutics is based in Frankfurt, Hessen.
The NAICS codes for Merz Therapeutics are [32, 3254, 32541, 325].
The SIC codes for Merz Therapeutics are [283, 28].